Geneticin (G418) Sulfate is an aminoglycoside antibiotic that has originally been derived from Micromonospora rhodoranga NRRL 5326. This compound has been shown to cause a bypass of nonsense mutations during translation. Experiments have shown that geneticin sulfate inhibits the incorporation of amino acids into protein and can destroy fibroblasts. Mechanistic studies suggest that this agent affects the 80S ribosome and inhibits the elongation cycle. Further studies report that geneticin sulfate is highly active against amoebae, protozoa, tapeworm, and pinworm exposed murine cells.
1. Wagman, G.H., et al. 1974. Antimicrob. Agents Chemother. 6: 144-149. PMID: 15828184
2. Bar-Nun, S., et al. 1983. Biochim. Biophys. Acta. 741: 123-127. PMID: 6193810
3. Halaban, R. and Alfano, F.D. 1984. In Vitro. 20: 447-450. PMID: 6724622
4. Yang, C., et al. 2007. Proc. Natl. Acad. Sci. U.S.A. 104: 15394-15399. PMID: 17881586
See how others have used Geneticin (G418) Sulfate. Click on the entry to view the PubMed entry .
PMID: # 26648003
Ying, Z. et al. 2015. Effect of Hath1 on the proliferation and apoptosis of cutaneous squamous cell carcinoma in vitro. Mol Med Rep. 12: 7845-50.
PMID: # 25757558
Ghose, J. et al. 2015. Transcriptional regulation of microRNA-100, -146a, and -150 genes by p53 and NFκB p65/RelA in mouse striatal STHdh(Q7)/ Hdh(Q7) cells and human cervical carcinoma HeLa cells. RNA Biol. 12: 457-77.
PMID: # 25286822
Tomellini, E. et al. 2015. Nerve growth factor and proNGF simultaneously promote symmetric self-renewal, quiescence, and epithelial to mesenchymal transition to enlarge the breast cancer stem cell compartment. Stem Cells. 33: 342-53.
PMID: # 25759266
Ismail, OZ. et al. 2015. Kidney injury molecule-1 protects against Gα12 activation and tissue damage in renal ischemia-reperfusion injury. Am. J. Pathol.. 185: 1207-15.
PMID: # 26697979
Ismail, O. et al. 2015. G protein, 12 (Gα12) is a negative regulator of kidney injury molecule-1-mediated efferocytosis. Am. J. Physiol. Renal Physiol.. ajprenal.00169.2015.
PMID: # 25526449
Hlaváč, V. et al. 2014. The role of cytochromes p450 and aldo-keto reductases in prognosis of breast carcinoma patients. Medicine (Baltimore). 93: e255.
PMID: # 25331979
Mateo, F. et al. 2014. SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer cell subpopulations. Molecular cancer. 13: 237.
PMID: # 25139909
Ryan, OW. et al. 2014. Selection of chromosomal DNA libraries using a multiplex CRISPR system. Elife. 3:
PMID: # 24606125
Eigler, T. et al. 2014. Constitutive somatostatin receptor subtype-3 signaling suppresses growth hormone synthesis. Mol. Endocrinol.. 28: 554-64.
PMID: # 23720720
Liu, Z. et al. 2013. Cell-cell contact-mediated hepatitis C virus (HCV) transfer, productive infection, and replication and their requirement for HCV receptors. J. Virol.. 87: 8545-58.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2017 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.